BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 812568)

  • 1. Tay-Sachs and Sandhoff-Jatzkewitz diseases: complementation of hexosaminidase A deficiency by somatic cell hybridization.
    Rattazzi MC; Brown JA; Davidson RG; Shows TB
    Birth Defects Orig Artic Ser; 1975; 11(3):232-5. PubMed ID: 812568
    [No Abstract]   [Full Text] [Related]  

  • 2. Tay-Sachs and Sandhoff diseases: an hypothesis about the primary lesion based on hexosaminidase patterns in interspecific hybrids.
    Van Cong N; Weil D; Rebourcet R; Pangalos C; Frézal J
    Birth Defects Orig Artic Ser; 1975; 11(3):272-5. PubMed ID: 812570
    [No Abstract]   [Full Text] [Related]  

  • 3. Tay-Sachs and Sandhoff-Jatzkewitz diseases: complementation of hexosaminidase A deficiency by somatic cell hybridization.
    Rattazzi MC; Brown JA; Davidson RG; Shows TB
    Cytogenet Cell Genet; 1975; 14(3-6):402-5. PubMed ID: 1192826
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on complementation of beta hexosaminidase deficiency in human GM2 gangliosidosis.
    Rattazzi MC; Brown JA; Davidson RG; Shows TB
    Am J Hum Genet; 1976 Mar; 28(2):143-54. PubMed ID: 817596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile Sandhoff Disease: complementation tests with Sandhoff and Tay-Sachs disease using polyethylene glycol-induced cell fusion.
    Wood S
    Hum Genet; 1978 Apr; 41(3):325-9. PubMed ID: 417993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tay-Sachs and Sandhoff diseases: an hypothesis about the primary lesion based on hexosaminidase patterns in interspecific hybrids.
    Cong NV; Weil D; Rebourcet R; Pangalos C; Frézal J
    Cytogenet Cell Genet; 1975; 14(3-6):442-5. PubMed ID: 1192834
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic complementation after fusion of Tay-Sachs and Sandhoff cells.
    Thomas GH; Taylor HA; Miller CS; Axelman J; Migeon BR
    Nature; 1974 Aug; 250(467):580-2. PubMed ID: 4367631
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic variants of hexosaminidase deficiency.
    Patrick AD
    Prog Clin Biol Res; 1977; 18():147-59. PubMed ID: 414238
    [No Abstract]   [Full Text] [Related]  

  • 9. [Reconstruction of hexosaminidase isoenzymes during hybridization of fibroblasts from Tay-Sachs and Sandhoff diseases].
    Beĭer EM; Vidershaĭn GIa; Venert M
    Biull Eksp Biol Med; 1984 Jan; 97(1):83-6. PubMed ID: 6229294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic study of GM2 gangliosidosis (Tay-Sachs and Sandhoff) by the study of the hexosaminidases of the Sandhoff-rodents hybrids (mouse and hamster)].
    Weil D; Van Cong N; Rebourcet R; Frézal J
    Ann Genet; 1975 Sep; 18(3):163-8. PubMed ID: 810067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of GM2-gangliosidosis (Tay-Sachs and Sandhoff disease) gene carriers by serum hexosaminidase assay.
    Molzer B; Bernheimer H
    Clin Chim Acta; 1976 Nov; 73(1):163-9. PubMed ID: 826357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of hexosaminadases in interspecific hybrids and in GM2 gangliosidosis with a discussion on their genetic control.
    Van Cong N; Weil D; Rebourcet R; Frézal J; Richard-Mollard AM
    Ann Hum Genet; 1975 Jul; 39(1):111-23. PubMed ID: 810068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inheritance of the enzyme defect in a new hexosaminidase deficiency disease.
    Johnson WG; Chutorian AB
    Ann Neurol; 1978 Nov; 4(5):399-403. PubMed ID: 104655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier detection in Sandhoff disease.
    Lowden JA; Ives EJ; Keene DL; Burton AL; Skomorowski MA; Howard F
    Am J Hum Genet; 1978 Jan; 30(1):38-45. PubMed ID: 414620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic complementation in somatic cell hybrids of four variants of infantile GM2 gangliosidosis.
    Sonderfeld S; Brendler S; Sandhoff K; Galjaard H; Hoogeveen AT
    Hum Genet; 1985; 71(3):196-200. PubMed ID: 2933318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sandhoff disease: impaired catabolism of sulfated glycosaminoglycans in cultured fibroblasts.
    Cantz M; O'Brien JF; Kresse H
    Birth Defects Orig Artic Ser; 1975; 11(6):261-7. PubMed ID: 127630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid hexosaminidase activity in Tay-Sachs and Sandhoff-Jatzkewitz diseases.
    Tomasi LG; Fukushima DK; Kolodny EH
    Neurology; 1974 Dec; 24(12):1158-65. PubMed ID: 4280528
    [No Abstract]   [Full Text] [Related]  

  • 18. Absence of hexosaminidase A and B in a normal adult.
    Dreyfus JC; Poenaru L; Svennerholm L
    N Engl J Med; 1975 Jan; 292(2):61-3. PubMed ID: 1109441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis.
    Sango K; McDonald MP; Crawley JN; Mack ML; Tifft CJ; Skop E; Starr CM; Hoffmann A; Sandhoff K; Suzuki K; Proia RL
    Nat Genet; 1996 Nov; 14(3):348-52. PubMed ID: 8896570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of residual hexosaminidase activity in Sandhoff's disease using man-Chinese hamster cell hybrids.
    Hoeksema HL; Reuser AJ; Hoogeveen AT; Westerveld A; Galjaard H
    Hum Genet; 1977 Dec; 39(3):315-9. PubMed ID: 413781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.